Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Joshua Harris"


3 mentions found


The visit was Staffan de Mistura’s first to the Western Sahara since he was appointed in 2021 to oversee U.N. efforts to guide negotiations that date back more than three decades. Morocco annexed Western Sahara, a former Spanish colony in 1975, sparking a conflict with the pro-independence Polisario Front. The region is believed to have considerable offshore oil deposits and mineral resources and is slightly larger than the United Kingdom. The United Nations said in a statement leading up to the trip that he “looked forward to further deepening consultations with all concerned on the prospects of constructively advancing the political process on Western Sahara,” and noted that the visit would precede the publication of a Western Sahara report to the Security Council next month. Morocco referenced its preferred plan to grant the region a form of self-governance that falls short of independence.
Persons: De Mistura, , Joe Biden hasn't, Mistura's, Joshua Harris, Washington's, Harris, Lounès, Organizations: UNITED NATIONS, United Nations, Polisario Front, Security, Trump, U.S, Embassy, APS, , Moroccan Autonomy Initiative Locations: Western, Morocco, Western Sahara, Spanish, Polisario, United Kingdom, United States, Israel, , North Africa, Rabat, Algiers, Algeria, Sahara, “ Morocco, Moroccan
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailCan A.I. Study finds 95% accuracy by listening to keyboard typingJoshua Harrison, software development engineer and A.I. researcher, joins 'Squawk Box' to discuss the use of A.I. to crack passwords, after researchers at Durham University trained an A.I. model to recognize passwords by listening to keystrokes with 95% accuracy, and more.
Persons: Joshua Harrison Organizations: Durham University
One of the biggest makers of generic drugs, Israeli-based Teva said it aims eventually to secure a 10% global market share of biosimilars. A division of Novartis (NOVN.S), Sandoz is currently the second biggest player after Pfizer Inc (PFE.N) in the biosimilar market by gross sales globally, per IQVIA data, cited by Sandoz. Sandoz launched eight biosimilar drugs between 2017 and 2021, including a version of Bristol-Myers’ multiple myeloma drug Revlimid. The analysis projected the value of the global biosimilar market could more than triple to an estimated $74 billion by 2030. Sandoz and Teva are both working on biosimilars for Humira.
Total: 3